Debt-to-equity of RHYTHM PHARMACEUTICALS, INC. from 30 Jun 2018 to 31 Dec 2025

Taxonomy & unit: ratio: %
Description: Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary: RHYTHM PHARMACEUTICALS, INC. quarterly Debt-to-equity in % history and change rate from 30 Jun 2018 to 31 Dec 2025.
RHYTHM PHARMACEUTICALS, INC. Debt-to-equity for the quarter ending 31 Dec 2025 was 300%, a 52% decline year-over-year.

Debt-to-equity, Quarterly (%)

Debt-to-equity, YoY Quarterly Change (%)

RHYTHM PHARMACEUTICALS, INC. Quarterly Debt-to-equity (%)

Period	Value	YoY Chg	Change %	Date
Q4 2025	300%	-326%	-52%	31 Dec 2025
Q3 2025	508%	+233%	+85%	30 Sep 2025
Q2 2025	2254%	+2101%	+1368%	30 Jun 2025
Q1 2025	948%	+842%	+799%	31 Mar 2025
Q4 2024	626%	+551%	+740%	31 Dec 2024
Q3 2024	274%	+213%	+348%	30 Sep 2024
Q2 2024	154%	+103%	+203%	30 Jun 2024
Q1 2024	105%	+60%	+133%	31 Mar 2024
Q4 2023	75%	+38%	+103%	31 Dec 2023
Q3 2023	61%	+33%	+114%	30 Sep 2023
Q2 2023	51%	+30%	+150%	30 Jun 2023
Q1 2023	45%	+31%	+228%	31 Mar 2023
Q4 2022	37%	+25%	+213%	31 Dec 2022
Q3 2022	29%	+18%	+164%	30 Sep 2022
Q2 2022	20%	+9.6%	+90%	30 Jun 2022
Q1 2022	14%	+3.7%	+36%	31 Mar 2022
Q4 2021	12%	+2.5%	+27%	31 Dec 2021
Q3 2021	11%	+2%	+23%	30 Sep 2021
Q2 2021	11%	+0.3%	+2.9%	30 Jun 2021
Q1 2021	10%	-2.2%	-18%	31 Mar 2021
Q4 2020	9.2%	-3%	-24%	31 Dec 2020
Q3 2020	8.8%	-2.2%	-20%	30 Sep 2020
Q2 2020	10%	+3%	+41%	30 Jun 2020
Q1 2020	12%	+7.8%	+175%	31 Mar 2020
Q4 2019	12%	+8.4%	+223%	31 Dec 2019
Q3 2019	11%	+7.6%	+224%	30 Sep 2019
Q2 2019	7.4%	+2.3%	+45%	30 Jun 2019
Q1 2019	4.5%			31 Mar 2019
Q4 2018	3.8%			31 Dec 2018
Q3 2018	3.4%			30 Sep 2018
Q2 2018	5.1%			30 Jun 2018

* An asterisk sign (*) next to the value indicates that the value is likely invalid.